Capital Research Global InvestorsCapital Research Global Investors

Institutional investor · Portfolio as of Q4 2020

Top Holdings404 positions

Checking export access…
Activity:

Microsoft Corp

95.5M$21.2B5.5%$97.41+117.72%
9 qtrssince 2018-Q4
Increased
63

Netflix Inc

30.2M$16.3B4.2%$27.84+94.23%
9 qtrssince 2018-Q4
Decreased
0

Broadcom Inc

32.5M$14.2B3.7%$22.17+76.67%
9 qtrssince 2018-Q4
Decreased
0

Facebook Inc

48.6M$13.3B3.4%$132.14+104.76%
9 qtrssince 2018-Q4
Decreased
0

Amazon.com Inc

4M$12.9B3.3%$77.36+110.52%
9 qtrssince 2018-Q4
Decreased
0

Abbott Laboratories

86.4M$9.5B2.5%$63.02+55.85%
9 qtrssince 2018-Q4
Decreased
0

UnitedHealth Group Inc

22M$7.7B2.0%$227.85+39.11%
9 qtrssince 2018-Q4
Decreased
0

Amgen Inc

31.8M$7.3B1.9%$156.83+22.73%
9 qtrssince 2018-Q4
Decreased
0

Gilead Sciences Inc

121.7M$7.1B1.8%$51.56-8.40%
9 qtrssince 2018-Q4
Increased
52

Mastercard Inc

18.8M$6.7B1.7%$210.51+64.02%
9 qtrssince 2018-Q4
Increased
55

Alphabet Inc

3.8M$6.6B1.7%$57.06+52.13%
9 qtrssince 2018-Q4
Increased
57

Comcast Corp

119.1M$6.2B1.6%$31.60+28.28%
9 qtrssince 2018-Q4
Increased
53

Philip Morris International In

64.6M$5.4B1.4%$49.62+27.68%
9 qtrssince 2018-Q4
Increased
53

Alphabet Inc

2.9M$5.1B1.3%$53.42+62.45%
9 qtrssince 2018-Q4
Increased
52

MercadoLibre Inc

2.9M$4.8B1.3%$389.67+329.91%
9 qtrssince 2018-Q4
Decreased
0

JPMorgan Chase & Co

37.7M$4.8B1.2%$92.45+19.03%
9 qtrssince 2018-Q4
Increased
72

CSX Corp

52.1M$4.7B1.2%$19.74+41.99%
9 qtrssince 2018-Q4
Increased
50

Thermo Fisher Scientific Inc

9.9M$4.6B1.2%$219.16+109.18%
9 qtrssince 2018-Q4
Decreased
0

Home Depot Inc/The

16.8M$4.5B1.2%$147.08+56.49%
9 qtrssince 2018-Q4
Decreased
0

Apple Inc

31M$4.1B1.1%$48.97+163.05%
9 qtrssince 2018-Q4
Decreased
0
$385.3B
AUM
404
Positions
Q4 2020
Filing
HI score · 4.0/5
Quarterly 13F Value Change
-3%Q3'19$304.9B+9%Q4'19$333.5B-24%Q1'20$254.9B+24%Q2'20$316.1B+5%Q3'20$333.1B+16%Q4'20$385.3B
Activity profile
$ moved · Q4'20
New9%Increased58%Decreased31%Exited3%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.5 years
<1Q6%1-4Q20%1-2Y16%2Y+58%

Capital Research Global Investors manages $385.3B across 404 positions as of Q4 2020. Top holdings: MSFT (5.5%), NFLX (4.2%), AVGO (3.7%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 4/5.0.

Q4 2020 Summary

Active quarter - 32 new positions, 33 exits, 208 increased. Top move: JPM (INCREASED, conviction 72). Portfolio: $385.3B across 404 positions.

Top holdings by portfolio weight

Total AUM$385B
MSFT5.51%
NFLX4.24%
AVGO3.69%
META3.45%
AMZN3.34%
ABT2.46%
UNH2.00%
AMGN1.90%
GILD1.84%
MA1.74%
Other1.72%

Portfolio allocation by GICS sector

Sectors11
Technology18.54%
Healthcare16.26%
Communication Services14.19%
Consumer Cyclical13.01%
Financial Services8.61%
Industrials8.05%
Consumer Defensive5.51%
Energy4.34%
Unknown3.17%
Utilities2.99%
Other5.35%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Healthcare, Communication Services
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Strong(4.0 / 5.0)
Holdings P&L64
Conviction42
Concentration56
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
MOMOALTRIA GROUP INC
Q4 2024 → Q2 2026+46.6M shares+$3.6B
7Q
AEPAEPAMERICAN ELEC PWR CO INC
Q4 2024 → Q2 2026+62,748 shares+$58M
7Q
APHAPHAmphenol Corporation
Q4 2024 → Q2 2026+25.2M shares+$4.9B
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used